Edition:
United States

Cidara Therapeutics Inc (CDTX.OQ)

CDTX.OQ on NASDAQ Stock Exchange Global Market

5.43USD
24 May 2018
Change (% chg)

$0.22 (+4.33%)
Prev Close
$5.20
Open
$5.25
Day's High
$5.45
Day's Low
$5.15
Volume
53,195
Avg. Vol
39,886
52-wk High
$8.80
52-wk Low
$3.72

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.802
FY 2017 Dec '17 0.00 -0.688
Sep '17 0.00 -0.727
Jun '17 0.00 -0.989
Mar '17 0.00 -0.798
FY 2016 Dec '16 0.00 -0.880
Sep '16 0.00 -0.879
Jun '16 0.00 -0.847
Mar '16 0.00 -0.709
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 6 0.00 0.00 0.00 0.39
Quarter Ending Sep-18 6 0.00 0.00 0.00 0.39
Year Ending Dec-18 7 0.00 0.00 0.00 1.18
Year Ending Dec-19 7 0.00 0.00 0.00 0.30
Earnings (per share)
Quarter Ending Jun-18 6 -0.70 -0.55 -0.83 -0.73
Quarter Ending Sep-18 6 -0.73 -0.56 -0.87 -0.75
Year Ending Dec-18 7 -3.01 -2.49 -3.29 -3.33
Year Ending Dec-19 6 -2.99 -1.94 -3.98 -2.88
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 236.60 32.60
P/E High - Last 5 Yrs. -- 289.72 47.30
P/E Low - Last 5 Yrs. -- 99.63 24.74
Beta -- 0.75 0.79
Price to Sales (TTM) -- 253.19 8.19
Price to Book (MRQ) 2.18 24.02 4.29
Price to Tangible Book (MRQ) 2.18 26.99 5.81
Price to Cash Flow (TTM) -- 135.81 21.74
% Owned Institutions 74.94 10.88 2.45

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.67
Dividend Yield - 5 Year Avg -- 0.20 0.80
Dividend 5 Year Growth Rate -- 2.27 4.06
Payout Ratio(TTM) -- 46.51 17.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 26.56 5.07
Sales (TTM) vs TTM 1 Yr. Ago -- 149.10 13.02
Sales - 5 Yr. Growth Rate -- 30.74 8.11
EPS (MRQ) vs Qtr. 1 Yr. Ago -0.49 -92.18 35.88
EPS (TTM) vs TTM 1 Yr. Ago 5.82 -- --
EPS - 5 Yr. Growth Rate -- 48.05 8.59
Capital Spending - 5 Yr. Growth Rate -- 39.82 8.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.65 2.53
Current Ratio (MRQ) 5.99 6.57 3.60
LT Debt to Equity (MRQ) 15.34 22.32 12.99
Total Debt to Equity (MRQ) 19.43 25.78 16.09
Interest Coverage (TTM) -- -182.04 35.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.26 55.04
Gross Margin - 5 Yr. Avg. -- 55.03 52.82
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -153.84 15.90
Operating Margin (TTM) -- -871.46 0.15
Operating Margin - 5 Yr. Avg. -- -166.48 11.15
Pre-Tax Margin (TTM) -- -758.30 2.24
Pre-Tax Margin - 5 Yr. Avg. -- -171.46 11.36
Net Profit Margin (TTM) -- -750.06 -1.19
Net Profit Margin - 5 Yr. Avg. -- -170.95 7.65
Effective Tax Rate (TTM) -- 14.72 31.40
Effective Tax Rate - 5 Yr. Avg. -- 19.46 24.33

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 21,974,635 724,115,471
Net Income/Employee (TTM) -968,508 -947,754 84,106,404
Receivable Turnover (TTM) -- 17.19 5.75
Inventory Turnover (TTM) -- 2.46 3.59
Asset Turnover (TTM) 0.00 0.42 0.86

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -72.49 -5.29 10.07
Return on Assets - 5 Yr. Avg. -- -0.38 11.08
Return on Investment (TTM) -81.71 -7.50 12.74
Return on Investment - 5 Yr. Avg. -- 2.94 14.36
Return on Equity (TTM) -93.11 -10.27 14.66
Return on Equity - 5 Yr. Avg. -- -2.81 15.72
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 4.21 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cidara Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 74.94%
# of Holders: 80
Total Shares Held: 16,030,267
3 Mo. Net Change: -1,236,120
# New Positions: 24
# Closed Positions: 8
# Increased Positions: 41
# Reduced Positions: 23
# Net Buyers: 18
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.